Active-ingredient Dossier
Moxonidine
Active-ingredient Dossier for Moxonidine (centrally acting antihypertensive). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: MOXONIDINE SCP
- Brand: PHYSIOTENS
- Brand: APO-MOXONIDINE
- Brand: ARX-MOXONIDINE
- Brand: MOXONIDINE
- Brand: MOXONIDINE
- Therapeutic area: Cardiology
What is
Moxonidine Moxonidine is a centrally acting antihypertensive.
Australian brands containing
Moxonidine — MOXONIDINE SCP — PHYSIOTENS — APO-MOXONIDINE — ARX-MOXONIDINE — MOXONIDINE — MOXONIDINE-WGR — MOXOTENS
Therapeutic areas
Moxonidine is registered in cardiology, with 9 brands containing the ingredient.
Sponsor landscape
Five sponsors market moxonidine: Southern Cross Pharma, Lupin, Viatris, Arrotex Pharmaceuticals, and GM Pharma.
PBS and regulatory activity
One brand containing moxonidine has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome for moxonidine is from 1 March 2006, and no AusPARs are on record.